BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21068051)

  • 1. Renal function and mortality following cardiac resynchronization therapy.
    Lin G; Gersh BJ; Greene EL; Redfield MM; Hayes DL; Brady PA
    Eur Heart J; 2011 Jan; 32(2):184-90. PubMed ID: 21068051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy.
    Singal G; Upadhyay GA; Borgquist R; Friedman DJ; Chatterjee NA; Kandala J; Park MY; Orencole M; Dec GW; Picard MH; Singh JP; Mela T
    Pacing Clin Electrophysiol; 2015 Oct; 38(10):1192-200. PubMed ID: 26179289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of renal insufficiency on long-term clinical outcome in patients with heart failure treated by cardiac resynchronization therapy.
    Hosoda J; Ishikawa T; Matsushita K; Matsumoto K; Kimura Y; Miyamoto M; Ogawa H; Takamura T; Sugano T; Ishigami T; Uchino K; Kimura K; Umemura S
    J Cardiol; 2012 Oct; 60(4):301-5. PubMed ID: 22763383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of renal function on the use of guideline-recommended therapies for patients with heart failure.
    Heywood JT; Fonarow GC; Yancy CW; Albert NM; Curtis AB; Stough WG; Gheorghiade M; McBride ML; Mehra MR; O'Connor CM; Reynolds D; Walsh MN
    Am J Cardiol; 2010 Apr; 105(8):1140-6. PubMed ID: 20381667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of difficult implantation procedure in cardiac resynchronization therapy.
    Bisch L; Da Costa A; Dauphinot V; Romeyer-Bouchard C; Khris L; M'baye A; Isaaz K
    Europace; 2010 Aug; 12(8):1141-8. PubMed ID: 20573673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional response to cardiac resynchronization therapy in patients with renal dysfunction and subsequent long-term mortality.
    Bogdan S; Klempfner R; Sabbag A; Luria D; Gurevitz O; Bar-Lev D; Lipchenca I; Nof E; Kuperstein R; Goldenberg I; Eldar M; Glikson M; Beinart R
    J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1188-95. PubMed ID: 24891182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome.
    van Bommel RJ; Borleffs CJ; Ypenburg C; Marsan NA; Delgado V; Bertini M; van der Wall EE; Schalij MJ; Bax JJ
    Eur Heart J; 2010 Nov; 31(22):2783-90. PubMed ID: 20693544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of long-term survival of men versus women with heart failure treated with cardiac resynchronization therapy.
    Mooyaart EA; Marsan NA; van Bommel RJ; Thijssen J; Borleffs CJ; Delgado V; van der Wall EE; Schalij MJ; Bax JJ
    Am J Cardiol; 2011 Jul; 108(1):63-8. PubMed ID: 21529733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
    Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
    Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
    Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR
    J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Renal Function on Survival After Cardiac Resynchronization Therapy.
    Kpaeyeh JA; Divoky L; Hyer JM; Daly DD; Maran A; Waring A; Gold MR
    Am J Cardiol; 2017 Jul; 120(2):262-266. PubMed ID: 28545627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of renal function on the long-term clinical course of patients who underwent percutaneous coronary intervention.
    Papafaklis MI; Naka KK; Papamichael ND; Kolios G; Sioros L; Sclerou V; Katsouras CS; Michalis LK
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):189-97. PubMed ID: 17253600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. End-stage renal disease predicts complications in pacemaker and ICD implants.
    Tompkins C; McLean R; Cheng A; Brinker JA; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1099-104. PubMed ID: 21489029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Goldenberg I; Hall WJ; Beck CA; Moss AJ; Barsheshet A; McNitt S; Polonsky S; Brown MW; Zareba W
    J Am Coll Cardiol; 2011 Aug; 58(7):729-37. PubMed ID: 21816309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.
    Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD;
    Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure.
    Yannopoulos D; Lurie KG; Sakaguchi S; Milstein S; Ermis C; VanHeel L; Benditt DG
    J Am Coll Cardiol; 2007 Sep; 50(13):1246-51. PubMed ID: 17888841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease in patients with chronic heart failure--impact on intracardiac conduction, diastolic function and prognosis.
    Bruch C; Rothenburger M; Gotzmann M; Wichter T; Scheld HH; Breithardt G; Gradaus R
    Int J Cardiol; 2007 Jun; 118(3):375-80. PubMed ID: 17049387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of renal function in patients with cardiac resynchronization therapy.
    Fung JW; Szeto CC; Chan JY; Zhang Q; Chan HC; Yip GW; Yu CM
    Int J Cardiol; 2007 Oct; 122(1):10-6. PubMed ID: 17174419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.
    Foley PW; Muhyaldeen SA; Chalil S; Smith RE; Sanderson JE; Leyva F
    Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.